Invention Grant
- Patent Title: Inhibitors of activin receptor-like kinase
-
Application No.: US15488257Application Date: 2017-04-14
-
Publication No.: US10233186B2Publication Date: 2019-03-19
- Inventor: Natasja Brooijmans , Jason D. Brubaker , Mark Cronin , Paul E. Fleming , Brian L. Hodous , Joseph L. Kim , Brett Williams , Douglas Wilson , Kevin J. Wilson
- Applicant: BLUEPRINT MEDICINES CORPORATION
- Applicant Address: US MA Cambridge
- Assignee: BLUEPRINT MEDICINES CORPORATION
- Current Assignee: BLUEPRINT MEDICINES CORPORATION
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
Abstract:
Described herein are compounds, such as compounds of formula (I) and pharmaceutically acceptable salts thereof, that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions
Public/Granted literature
- US20170298069A1 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE Public/Granted day:2017-10-19
Information query
